SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles

Front Cell Infect Microbiol. 2021 Apr 23:11:663688. doi: 10.3389/fcimb.2021.663688. eCollection 2021.

Abstract

The establishment of SARS CoV-2 spike-pseudotyped lentiviral (LV) systems has enabled the rapid identification of entry inhibitors and neutralizing agents, alongside allowing for the study of this emerging pathogen in BSL-2 level facilities. While such frameworks recapitulate the cellular entry process in ACE2+ cells, they are largely unable to factor in supplemental contributions by other SARS CoV-2 genes. To address this, we performed an unbiased ORF screen and identified the nucleoprotein (N) as a potent enhancer of spike-pseudotyped LV particle infectivity. We further demonstrate that the spike protein is better enriched in virions when the particles are produced in the presence of N protein. This enrichment of spike renders LV particles more infectious as well as less vulnerable to the neutralizing effects of a human IgG-Fc fused ACE2 microbody. Importantly, this improvement in infectivity is observed with both wild-type spike protein as well as the D614G mutant. Our results hold important implications for the design and interpretation of similar LV pseudotyping-based studies.

Keywords: ACE2-Fc; SARS-CoV-2; nucleocapsid; spike lentiviral pseudotyping; virus neutralization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Humans
  • Nucleoproteins / genetics
  • SARS-CoV-2
  • Severe acute respiratory syndrome-related coronavirus* / genetics
  • Spike Glycoprotein, Coronavirus / genetics

Substances

  • Nucleoproteins
  • Spike Glycoprotein, Coronavirus